Norges Bank’s RxSight RXST Stock Holding History

Norges Bank’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-325,500	Closed	-$9.08M	–	1997
2023 Q3	$9.08M	Buy	325,500 +140,000	+75%	+$4.17M	﹤0.01%	1513
2023 Q2	$5.34M	Buy	+185,500	New	+$4.13M	﹤0.01%	1706

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank's RXST Position: Q4 2023 in Review

Norges Bank sold out of RxSight (RXST) in Q4 2023, closing a stake of 325,500 shares — an estimated $9.08M sold.

Norges Bank first reported a position in RXST in Q2 2023 and held it in 2 quarters. The position peaked at $9.08M in Q3 2023. 169 funds tracked by Wall St. Rank hold RXST as of Q4 2023.

Norges Bank reported no remaining RxSight position as of Q4 2023 after selling out during the quarter.
Norges Bank sold 325,500 RxSight shares in Q4 2023, an estimated $9.08M.
Norges Bank first reported a position in RxSight in Q2 2023 and held it in 2 quarters.
Norges Bank's RxSight position peaked at $9.08M in Q3 2023.
169 funds tracked by Wall St. Rank held RxSight as of Q4 2023.

Based on Norges Bank's 13F filing for Q4 2023, filed 9 Feb 2024.